Contact us at 914-666-4665

April 29, 2021

immune modulating lyme disease

Immune modulating drug affects Lyme disease test, delays diagnosis

Welcome to another Inside Lyme Podcast. I am your host Dr. Daniel Cameron. I find that the best way to get to know Lyme disease is through reviewing actual cases. In this episode, I will be discussing the case of a young woman with multiple sclerosis (MS), who had a delay in diagnosis of Lyme disease […]

Immune modulating drug affects Lyme disease test, delays diagnosis Read More »

B cell suppressive therapy led to a delayed diagnosis of Lyme disease

I will be discussing a 20-year-old girl with a 3 year history of multiple sclerosis treated with B cell suppressive therapy . She was prescribed two biological disease-modifying antirheumatic drug (DMARD). This article was written by Sjowall and colleagues in the journal Frontiers in Neurology. She was initially prescribed tocilizumab, marketed in the US as

B cell suppressive therapy led to a delayed diagnosis of Lyme disease Read More »